NCT00911157

The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese Patients

Name: Clinical Trial NCT00911157
Creator: GlaxoSmithKline
Keywords: Thrombosis, Venous, Fondaparinux sodium, Phase 3, drug, clinical trial, Japan

Clinical Evaluation of GSK576428 (Fondaparinux Sodium) in the Treatment of Acute Deep Vein Thrombosis (DVT)

GlaxoSmithKline·Phase 3·ClinicalTrials.gov·drugCompleted

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Thrombosis, Venous
Drug/Device/Intervention: Fondaparinux sodium
Study type: Interventional
Intervention type: drug

Sponsor & location

Primary sponsor: GlaxoSmithKline
Location: Aichi,Fukuoka,Gunma,Gunma,Hiroshima,Hiroshima,Hokkaido,Hokkaido,Hokkaido,Hyogo,Ibaraki,Ibaraki,Kagoshima,Kanagawa,Kumamoto,Kumamoto,Mie,Nagano,Nagasaki,Niigata,Okayama,Shizuoka,Shizuoka,Tokyo, Japan

Timeline & enrollment

Phase: Phase 3
Start date: Jun 01, 2008
End date: Nov 01, 2009
Enrollment: 39 participants

Primary outcome

Percentage of Participants With Recurrent or New Symptomatic Venous Thromboembolism (VTE)

Summary

The primary objective of this study is to evaluate the efficacy (as measured by the rate of recurrent symptomatic Venous Thromboembolism [VTE] (i.e., Pulmonary thromboembolism [PE] and Deep Vein Thrombosis [DVT])) and safety of GSK576428 as the initial treatment in subjects with acute symptomatic DVT in an open-label design.

ICD-10 classifications

Other venous embolism and thrombosisEmbolism and thrombosis of unspecified veinEmbolism and thrombosis of other specified veinsPerianal venous thrombosisArterial embolism and thrombosis

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT00911157
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT00911157 through Pure Global AI's free database. This Phase 3 trial is sponsored by GlaxoSmithKline and is currently Completed. The study focuses on Thrombosis, Venous. Target enrollment is 39 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.